Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

A Better Family Plan

Staff  |  Issue: October 2007  |  October 1, 2007

As women with systemic lupus erythematosus (SLE) live longer and healthier lives, more and more are asking whether they can or should become pregnant. Forty years ago, a rheumatologist would have been correct to discourage a woman with SLE who wanted to have a child; the rate of pregnancy loss for a woman with SLE was more than 40% at that time. In recent years, however, the success rate of SLE pregnancies has increased significantly. Currently, the risk of pregnancy loss for someone with SLE is roughly equivalent to that of a healthy woman.1 However, pregnancy in a woman with SLE is not always without complication.

Risks to the Fetus and Child

The birth of a healthy full-term baby following an easy pregnancy is the goal of every woman, but it may not be the reality for many women with SLE. Though fewer women with SLE will lose their pregnancy than in previous decades, many are still at increased risk for preterm birth. In general, a third of all SLE pregnancies deliver early – meaning prior to 37 weeks of gestation – and a significant minority will deliver in the even more dangerous period prior to 32 weeks gestation.2 Though most babies born to women with SLE are healthy, neonatal lupus manifesting as congenital heart block can occur in up to 2% of babies exposed to Ro/SSA and/or La/SSB antibodies.3 The immune system of babies born to women with SLE appears to be functionally intact, with few reports of significant infections or lasting immunodeficiency.4 While most children born to women with SLE have normal development and intelligence, there may be a modest increase in the rate of learning disabilities in elementary school–age boys.5 A small proportion of offspring (around 10%) will develop an autoimmune disease at some point in life.6

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Risks to the Mother

The risks to the pregnant woman with SLE are low, but present. The maternal mortality rate among women with SLE is 20-fold higher than the maternal mortality for healthy women in the U.S.7 Though this risk may appear high, the absolute risk of death during the year of pregnancy does not appear to be greater than any other year that a woman lives with SLE. In a nationwide study of SLE pregnancies, the maternal mortality rate was 0.325%; the annual mortality rate for a non-pregnant woman with lupus is several times higher – between 0.7% and 2.5% in most studies.8,9 This study also found that increased risks for stroke, deep vein thrombosis, infection, and hematologic abnormalities among women with SLE were higher than in the general population. Up to one quarter of women with SLE will develop preeclampsia (hypertension and proteinuria related to pregnancy). The bulk of the evidence points to a modestly increased risk for SLE activity during pregnancy. Fortunately, severe SLE flares in pregnancy are not common, and the majority of symptoms are related to musculoskeletal and cutaneous disease.

Page: 1 2 3 4 5 6 7 8 | Single Page
Share: 

Filed under:ConditionsSystemic Lupus Erythematosus Tagged with:Diagnostic CriteriaPathogenesispregnancySLEsystemic lupus erythematosus (SLE)systemic lupus erythematous

Related Articles

    Rheumatologists Should Discuss with Patients Use of Immunomodulatory Agents During Pregnancy

    November 16, 2016

    The decision to continue or discontinue immunomodulatory medications during pregnancy is a difficult one for both patients and physicians. On the one hand, when left untreated, rheumatic conditions can cause harm to an unborn child, as well as to the pregnant mother. On the other hand, medications can be harmful to a developing fetus. In…

    Challenges in Reproductive Health in Rheumatic Disease

    July 11, 2022

    In light of new challenges to individuals’ reproductive rights and the known challenges of clinical management of rheumatic disease patients during pregnancy, we review the current state of reproductive rheumatology and the management of patients with rheumatic disease during pregnancy.

    Treat to Target: Rheumatoid Arthritis in Pregnant Patients

    October 1, 2012

    A treat-to-target approach to managing rheumatoid arthritis can work even in pregnant women

    AndreyCherkasov / Shutterstock.com

    Rheumatic Disease Does Not Preclude Pregnancy

    November 9, 2017

    Preconception planning is essential to help women with autoimmune disease have optimal pregnancy outcomes. Unplanned pregnancy can also negatively impact disease course in some patients. Yet many rheumatologic patients of childbearing age do not receive adequate contraception or prepregnancy education and counseling. Rheumatologists must work collaboratively with other healthcare providers to make sure rheumatic patients…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences